Patent details

EP1733732 Title: INSULIN RESISTANCE IMPROVING AGENT

Basic Information

Publication number:
EP1733732
PCT Application Number:
PCT/JP/2005/005472
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057214496
PCT Publication Number:
WO/2005/092349
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
INSULIN RESISTANCE IMPROVING AGENT
French Title of Invention:
AGENT AMELIORANT LA RESISTANCE A L INSULINE
German Title of Invention:
MITTEL ZUR VERBESSERUNG DER INSULINRESISTENZ
SPC Number:

Dates

Filing date:
25/03/2005
Grant date:
10/10/2012
EP Publication Date:
10/10/2012
PCT Publication Date:
06/10/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/12/2006
EP B1 Publication Date:
10/10/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/03/2013
Expiration date:
25/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/03/2005
 
 

Name:
Mitsubishi Tanabe Pharma Corporation
Address:
2-10, Dosho-machi 3-chome Chuo-ku, Osaka-shi Osaka 541-8505, Japan (JP)

Inventor

1

Name:
SUZUKI Kazuo, c/o MITSUBISHI PHARMA CORPORATION
Address:
Japan (JP)

2

Name:
NAKAJIMA Shigekazu, c/o MITSUBISHI PHARMA CORP.
Address:
Japan (JP)

3

Name:
SUGIMOTO Kanami c/o MITSUBISHI PHARMA CORPORATION
Address:
Japan (JP)

Priority

Priority Number:
2004091508
Priority Date:
26/03/2004
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 31/785;

Publication

European Patent Bulletin

Issue number:
202020
Publication date:
13/05/2020
Description:
Opposition rejected; Patent maintained as granted
Filing date Document type Number of pages